Responses
Poster Presentations
Rheumatoid arthritis - prognosis, predictors and outcome
THU0126 Added-Value of Combining Methotrexate with a Biological Agent Compared to Biological Monotherapy in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomised Trials
Compose a Response to This Article
Other responses
No responses have been published for this article.